We are live on ! Find out more
CORV

Correvio Pharma Corp. Ordinary Shares (Canada)
CORV

Delisted

CORV was delisted on the 26th of May, 2020.

27 hedge funds and large institutions have $35M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

419% more capital invested

Capital invested by funds: $6.75M → $35M (+$28.3M)

42% more funds holding

Funds holding: 1927 (+8)

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

96% less call options, than puts

Call options by funds: $36K | Put options by funds: $826K

Holders
27
Holders Change
+8
Holders Change %
+42.11%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
7
Reduced
5
Closed
1
Calls
$36K
Puts
$826K
Net Calls
-$790K
Net Calls Change
-$473K
Name Holding Trade Value Shares
Change
Change in
Stake
KIA
26
Kopp Investment Advisors
Minnesota
-$61K -17,280 Closed
Bank of America
27
Bank of America
North Carolina
-$1.05K -200 -75%

CORV Hedge Fund Activity: Q4 2013 in Review

27 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2013, worth a combined $35M — up 419% from $6.75M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CORV positions and 1 closed out — a net gain of 8 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Fortress Investment Group, opening a new position worth an estimated $13M. The largest seller was Deutsche Bank, cutting an estimated $93.8K.

  • 27 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2013, up from 19 in Q3 2013.
  • Funds reported $35M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2013, up 419% quarter-over-quarter.
  • 9 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2013 and 1 closed out, a net change of +8 holders.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2013 was Fortress Investment Group, an estimated $13M added.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2013 was Deutsche Bank, an estimated $93.8K sold.

Based on aggregated 13F filings for Q4 2013.